ロード中...
Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy
BACKGROUND: Alpha lipoic acid (ALA), a type of antioxidant, is used in combination with epalrestat in the treatment of diabetic peripheral neuropathy (DPN). However, whether combined treatment is superior to epalrestat monotherapy is controversial. METHODS: We conducted a systematic search of PubMed...
保存先:
| 出版年: | Drug Des Devel Ther |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6135078/ https://ncbi.nlm.nih.gov/pubmed/30233145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S168878 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|